Anticoagulant Market Research Report by Route of Administration, by Anticoagulant Drug, by Drug Class, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

January 2021
186 pages
ID: 5913204
Format: PDF
360iResearch

Up to $995 off Until Feb 28th 2021

Summary

Table of Contents

Anticoagulant Market Research Report by Route of Administration (Injectable Anticoagulants and Oral Anticoagulants), by Anticoagulant Drug (Betrixaban, Dabigatran, Edoxaban / Rivaroxaban, and Eliquis), by Drug Class, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Anticoagulant Market is expected to grow from USD 30,352.47 Million in 2020 to USD 46,946.45 Million by the end of 2025.
2. The Global Anticoagulant Market is expected to grow from EUR 26,613.63 Million in 2020 to EUR 41,163.54 Million by the end of 2025.
3. The Global Anticoagulant Market is expected to grow from GBP 23,659.57 Million in 2020 to GBP 36,594.48 Million by the end of 2025.
4. The Global Anticoagulant Market is expected to grow from JPY 3,239,378.74 Million in 2020 to JPY 5,010,376.90 Million by the end of 2025.
5. The Global Anticoagulant Market is expected to grow from AUD 44,075.83 Million in 2020 to AUD 68,172.50 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Anticoagulant to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Oral Anticoagulants is projected to witness the highest growth during the forecast period"

Based on Route of Administration, the Anticoagulant Market studied across Injectable Anticoagulants and Oral Anticoagulants. The Oral Anticoagulants commanded the largest size in the Anticoagulant Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.

"The Edoxaban / Rivaroxaban is projected to witness the highest growth during the forecast period"

Based on Anticoagulant Drug, the Anticoagulant Market studied across Betrixaban, Dabigatran, Edoxaban / Rivaroxaban, and Eliquis. The Edoxaban / Rivaroxaban commanded the largest size in the Anticoagulant Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.

"The Heparin is projected to witness the highest growth during the forecast period"

Based on Drug Class, the Anticoagulant Market studied across DTIs, Factor XA Inhibitors, Heparin, and Vitamin K Antagonists. The DTIs commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Heparin is expected to grow at the fastest CAGR during the forecast period.

"The Deep Vein Thrombosis is projected to witness the highest growth during the forecast period"

Based on Application, the Anticoagulant Market studied across Atrial fibrillation & Heart Attack, Deep Vein Thrombosis, Pulmonary Embolism, and Stroke. The Atrial fibrillation & Heart Attack commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Deep Vein Thrombosis is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Anticoagulant Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Anticoagulant Market including Akebia Therapeutics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, Athenex, Inc., Baxter Laboratories Pty Ltd., Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Sandoz International GmbH, Sanofi S.A., and Teva Pharmaceutical Industries Ltd..

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Anticoagulant Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Anticoagulant Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anticoagulant Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anticoagulant Market?
4. What is the competitive strategic window for opportunities in the Global Anticoagulant Market?
5. What are the technology trends and regulatory frameworks in the Global Anticoagulant Market?
6. What are the modes and strategic moves considered suitable for entering the Global Anticoagulant Market?

Our reports have been used by over 10K customers, including:

Get Industry Insights. Simply.

Latest reports & slideshows with insights from top research analysts
150+ Million searchable statistics with tables, figures & datasets
More than 25,000 trusted sources

10% Off

$4949

Single User License — provides access to the report by one individual.
Department License — allows you to share the report with up to 5 users
Site License — allows the report to be shared amongst all employees in a defined country
Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ

How we can help
- I am not sure if the report I am interested in will fulfill my needs. Can you help me?
- Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
- We buy reports often - can ReportLinker get me any benefits?
- Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
- I have had negative experiences with market research reports before. How can you avoid this from happening again?
- We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.
Report Delivery
- How and when I will receive my Report?
- Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
Payment conditions
- What payment methods do you accept?
- 1. Credit card : VISA, American Express, Mastercard, or
  2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
  3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
- What are ReportLinker’s Payment Terms?
- All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
- Are Taxes and duties included?
- All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
- I’m not satisfied. Can I be refunded?
- No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
User license
- The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.